Search research articles
Contact Us
Filters
Showing results (121-130 of 336) with videos related to
Page
of 34
Sort By:
Scientific Reports
|
February 7, 2020
Author Correction: Validation of the GRade, Age, Nodes and Tumor (GRANT) score within the Surveillance Epidemiology and End Results (SEER) database: A new tool to predict survival in surgically treated renal cell carcinoma patients
Sebastiano Buti, Pierre I Karakiewicz, Melissa Bersanelli, et al.
Current Oncology Reports
|
December 23, 2025
Host-related Determinants of Response to Immunotherapy in Non-small Cell Lung Cancer: The Interplay of Body Composition, Metabolism, Sex and Immune Regulation
Valentina Santo, Leonardo Brunetti, Federica Pecci, et al.
Cancer Medicine
|
January 2, 2024
Concomitant antihypertensive medication and outcome of patients with metastatic castration-resistant prostate cancer receiving enzalutamide or abiraterone acetate
Ondřej Fiala, Petr Hošek, Hana Korunková, et al.
Communications Medicine
|
May 27, 2026
Microplastics as both a driver of genitourinary cancers and a deliverer of treatments
Kannan Sridharan, Brigida Anna Maiorano, Farah Rehan, et al.
Lung Cancer (Amsterdam, Netherlands)
|
February 19, 2017
Analysis of a panel of druggable gene mutations and of ALK and PD-L1 expression in a series of thymic epithelial tumors (TETs)
Marcello Tiseo, Angela Damato, Lucia Longo, et al.
Plos One
|
February 28, 2017
Benefit of adjuvant immunotherapy in renal cell carcinoma: A myth or a reality?
Satoru Taguchi, Sebastiano Buti, Hiroshi Fukuhara, et al.
The Oncologist
|
February 15, 2026
A prospective external validation of the GRade, Age, Nodes and Tumor (GRANT) score in the ECOG-ACRIN EA8143 PROSPER trial
Sebastiano Buti, Se-Eun Kim, Michele Maffezzoli, et al.
Clinical Genitourinary Cancer
|
January 31, 2024
Impact of Metastatic Site in Favorable-Risk Renal Cell Carcinoma Receiving Sunitinib or Pazopanib
Martina Catalano, Ugo De Giorgi, Davide Bimbatti, et al.
Tumori
|
September 29, 2021
Transient asymptomatic pulmonary opacities and interstitial lung disease in <i>EGFR</i>-mutated non-small cell lung cancer treated with osimertinib
Gianluca Taronna, Alessandro Leonetti, Filippo Gustavo Dall'Olio, et al.
JAMA Oncology
|
April 14, 2022
Cabozantinib as First-line Treatment in Patients With Metastatic Collecting Duct Renal Cell Carcinoma: Results of the BONSAI Trial for the Italian Network for Research in Urologic-Oncology (Meet-URO 2 Study)
Giuseppe Procopio, Pierangela Sepe, Melanie Claps, et al.
Page
of 34
Search research articles
Search
Showing results (121-130 of 336) with videos related to
Sort By:
Page
of 34
Scientific Reports
|
February 7, 2020
Author Correction: Validation of the GRade, Age, Nodes and Tumor (GRANT) score within the Surveillance Epidemiology and End Results (SEER) database: A new tool to predict survival in surgically treated renal cell carcinoma patients
Sebastiano Buti, Pierre I Karakiewicz, Melissa Bersanelli, et al.
Current Oncology Reports
|
December 23, 2025
Host-related Determinants of Response to Immunotherapy in Non-small Cell Lung Cancer: The Interplay of Body Composition, Metabolism, Sex and Immune Regulation
Valentina Santo, Leonardo Brunetti, Federica Pecci, et al.
Cancer Medicine
|
January 2, 2024
Concomitant antihypertensive medication and outcome of patients with metastatic castration-resistant prostate cancer receiving enzalutamide or abiraterone acetate
Ondřej Fiala, Petr Hošek, Hana Korunková, et al.
Communications Medicine
|
May 27, 2026
Microplastics as both a driver of genitourinary cancers and a deliverer of treatments
Kannan Sridharan, Brigida Anna Maiorano, Farah Rehan, et al.
Lung Cancer (Amsterdam, Netherlands)
|
February 19, 2017
Analysis of a panel of druggable gene mutations and of ALK and PD-L1 expression in a series of thymic epithelial tumors (TETs)
Marcello Tiseo, Angela Damato, Lucia Longo, et al.
Plos One
|
February 28, 2017
Benefit of adjuvant immunotherapy in renal cell carcinoma: A myth or a reality?
Satoru Taguchi, Sebastiano Buti, Hiroshi Fukuhara, et al.
The Oncologist
|
February 15, 2026
A prospective external validation of the GRade, Age, Nodes and Tumor (GRANT) score in the ECOG-ACRIN EA8143 PROSPER trial
Sebastiano Buti, Se-Eun Kim, Michele Maffezzoli, et al.
Clinical Genitourinary Cancer
|
January 31, 2024
Impact of Metastatic Site in Favorable-Risk Renal Cell Carcinoma Receiving Sunitinib or Pazopanib
Martina Catalano, Ugo De Giorgi, Davide Bimbatti, et al.
Tumori
|
September 29, 2021
Transient asymptomatic pulmonary opacities and interstitial lung disease in <i>EGFR</i>-mutated non-small cell lung cancer treated with osimertinib
Gianluca Taronna, Alessandro Leonetti, Filippo Gustavo Dall'Olio, et al.
JAMA Oncology
|
April 14, 2022
Cabozantinib as First-line Treatment in Patients With Metastatic Collecting Duct Renal Cell Carcinoma: Results of the BONSAI Trial for the Italian Network for Research in Urologic-Oncology (Meet-URO 2 Study)
Giuseppe Procopio, Pierangela Sepe, Melanie Claps, et al.
Page
of 34